Sagimet Biosciences: Making The Bull Case For Differentiated Denifanstat
Madrigal Pharmaceuticals Inc MDGL
$523.69
▼ -3.00%
($-16.20)
Open
$540.56
Prev Close
$539.89
Day Range
$522.40 – $543.78
52W Range
$265.00 – $615.00
Market Cap
$12.07B
Beta
-1.09
EPS (TTM)
$-13.63
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2007-02-06 |
| Shares Out. | 22,940,000 |
| Website | madrigalpharma.com/ ↗ |
| Phone | 13026587581 |
Madrigal Pharmaceuticals Inc is a publicly traded company under the ticker symbol MDGL on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
23 analysts (2026-05-01)
📰 Latest News for MDGL
Truist Securities Maintains Buy on Madrigal Pharmaceuticals, Raises Price Target to $709
Madrigal Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation
Canaccord Genuity Maintains Buy on Madrigal Pharmaceuticals, Lowers Price Target to $578
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Evercore ISI Group Maintains Outperform on Madrigal Pharmaceuticals, Lowers Price Target to $649
Earnings Scheduled For May 6, 2026
Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2026 Earnings Call Transcript